Abstract
A detailed casenote review was performed on 55 patients registered with testicular non-seminomatous germ cell tumours (NSGCT) between 1983 and 1988 under the Scottish Cancer Registration Scheme and who had died by 1992. Details of all aspects of clinical management relating to their NSGCT and death details were extracted and summarised. An assessment was made on whether the patients' management had been optimal. An analysis of 5 year survival rates by the five Scottish oncology centres demonstrated significant differences between centres (range 70.4-94.2; chi 2 = 14.46, d.f. = 4, P = 0.006). Some patients in all centres were assessed as having received suboptimal treatment, but two centres performed less well than the other three. There is a suggestion that the number of patients treated suboptimally decreases with increasing number of patients seen, but this does not reach statistical significance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Howard, G., Clarke, K., Elia, M. et al. A Scottish national mortality study assessing cause of death, quality of and variation in management of patients with testicular non-seminomatous germ-cell tumours. Br J Cancer 72, 1307–1311 (1995). https://doi.org/10.1038/bjc.1995.506
Issue Date:
DOI: https://doi.org/10.1038/bjc.1995.506
This article is cited by
-
Interdisziplin�re Kooperation in der Therapie von komplexen Patienten mit fortgeschrittenem testikul�rem Keimzelltumor
Der Urologe, Ausgabe A (2004)
-
Access to specialist cancer care: is it equitable?
British Journal of Cancer (2002)